Citation Impact
Citing Papers
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851
1992
Multiple myeloma
2014
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
1999
Classification and Grading of Gastritis
1996 Standout
Is P-Glycoprotein a Sufficient Marker for Multidrug Resistance in Vivo? Immunohistochemical Staining for P-Glycoprotein in Children and Adult Leukemia: Correlation with Clinical Outcome
1995
Parenteral Nutrition Does Not Stimulate Tumor Proliferation in Malnourished Gastric Cancer Patients
2007
Cell production rates in human tissues and tumours and their significance. Part II: clinical data
2000
A rapid immunogold-silver staining for detection of bromodeoxyuridine in large numbers of plastic sections, using microwave irradiation
1990
Clinical translation of angiogenesis inhibitors
2002 Standout
Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease
2003
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
A predictive model for the clinical response to low dose ara‐C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia
1992
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
1998 Standout
Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy
1995
MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE
1999
Modulation of cell cycle kinetics in human cancer with total parenteral nutrition
1992
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors
1990
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Multiple Myeloma
2004
Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer
2000 Standout
Neurogenesis in the adult human hippocampus
1998 Standout
Current Therapy for Multiple Myeloma
2002
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
1996 Standout
The biological and clinical significance of the KI‐67 growth fraction in multiple myeloma
1992
Polymer conjugates as anticancer nanomedicines
2006 Standout
Session 5: Morphology and Pathogenesis of Endocrine Hyperplasias, Precarcinoid Lesions, and Carcinoids Arising in Chronic Atrophic Gastritis
1991
The myelodysplastic syndrome.
1989
Recent Advances in the Treatment of Breast Cancer
1991
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
NF-κB and IKK as therapeutic targets in cancer
2006 Standout
Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies
1995
Pre-operative nutritional support and tumour cell kinetics in malnourished patients with gastric cancer
1991
Hypocellular myelodysplastic syndromes (MDS): new proposals
1995
Fadiga relacionada ao câncer: uma revisão
2011 Standout
Monoclonal Gammopathy of Undetermined Significance
2005
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Gastric cancer
2020 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Gill epithelial cells kinetics in a freshwater teleost, Oncorhynchus mykiss during adaptation to ion-poor water and hormonal treatments
1994
Mechanisms of Bone Metastasis
2004 Standout
Original articles
1991
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
1997 Standout
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry
1988
Hypoplastic Myelodysplastic Syndromes Can Be Distinguished From Acquired Aplastic Anemia by CD34 and PCNA Immunostaining of Bone Marrow Biopsy Specimens
1997
The dawning era of polymer therapeutics
2003 Standout
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Effect of exercise on the caloric intake of breast cancer patients undergoing treatment
2008
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Prognostic value of S‐phase cells in AML patients
1995
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.
1994 Standout
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
2002 Standout
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies
1992
Breast Cancer Statistics, 2022
2022 Standout
Clinical Studies with Modulators of Multidrug Resistance
1995
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Radiosurgery for malignant meningioma: results in 22 patients
2000 StandoutNobel
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry
1992
Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM Variants
1999
Morphology and classification of the myelodysplastic syndromes and their pathologic variants.
1996
The beginning of pattern formation in theDrosophilacompound eye: the morphogenetic furrow and the second mitotic wave
1991
The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS
2000
The linear-quadratic formula and progress in fractionated radiotherapy
1989 Standout
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry
1992
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma
1994
Analysis of genetic mosaics in developing and adult Drosophila tissues
1993 Standout
All You Wanted to Know About Spermatogonia but Were Afraid to Ask
2000 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Multiple Myeloma
2011 Standout
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]
1993
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Erythropoietin or darbepoetin for patients with cancer
2012
Review : Synthetic Polymers with Intrinsic Anticancer Activity
1991
Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
2000
International Staging System for Multiple Myeloma
2005 Standout
Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.
1997
Works of G. Ucci being referenced
Refractory cytopenias: Clinical course according to bone marrow cytology and cellularity
1987
A prognostic index for multiple myeloma
1996
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients
2008
In vivo bromodeoxyuridine incorporation in human gastric cancer: A study on formalin-fixed and paraffin-embedded sections
1988
Expression of p170 protein in multiple myeloma: A clinical study
1992
Cell kinetics of human brain tumors: In vivo study with bromodeoxyuridine and flow cytometry
1988
Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study
1990
Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma
1987
Monoclonal Antibody Ki-67 as a Marker of Proliferative Activity in Monoclonal Gammopathies
1991
Changing clinical presentation of multiple myeloma
1991
Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases
1993
Prognostic parameters in myelodysplastic syndromes: A multiple regression analysis
1988
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly
2007
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: Clinical significance in acute non-lymphoblastic leukaemia
1991
Flow cytometric analysis of paraffin-embedded material in human gastric cancer.
1988
Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
1986
Clinical trial of high doses of Bay I 7433 (Copovithane).
1986
Flow cytometric DNA content in myelodysplastic syndromes
1983
Adult acute non‐lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S‐phase size determined by flow cytofluorometry
1986
Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.
1985
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
1988
Serum Thymidine Kinase and Beta-2 Microglobulin in Monoclonal Gammopathies
1987
Analysis of Human Myeloma Cell Population Kinetics
1986